Sign in
4

Changes in Ownership

PUMA BIOTECHNOLOGY, INC. Filed Acc 0001437749-23-003379

Chief Commercial Officer acquired 66,972 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ludwig Jeffrey Jerome Chief Commercial Officer 2023-02-10 Grant or award +66,972 125,029 D
Derivatives
Ludwig Jeffrey Jerome Chief Commercial Officer 2023-02-10 Grant or award · Stock Option (Right to Buy) +93,028 93,028 D
Loading xslF345X03/rdgdoc.xml…